About
Biological Industries is a global supplier for the life sciences industry. With over 30 years' experience in cell culture media development and manufacturing, the company has supplied products to and collaborated with a wide range of academic institutions and biotechnology companies.
Biological Industries' products include cell culture media, supplements, reagents for stem cell research and potential cell therapy applications, and serum-free media. In addition to its advanced manufacturing and quality control systems, the company has regulatory experience, in-depth market knowledge, and extensive training and R&D capabilities.
The company supplies life science products to the biopharmaceutical industry, universities, government research organizations, and healthcare institutions.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Biological Industries acquired and by whom?
- Biological Industries was acquired by Sartorius in May 2019.
- What is Biological Industries' primary focus within the life sciences industry?
- Biological Industries specializes in cell culture media development and manufacturing, supplying products for research and diagnostics, including stem cell research and cell therapy applications.
- Where is Biological Industries headquartered?
- Biological Industries is headquartered in Beit HaEmek, Israel.
- What was a significant product addition to Biological Industries USA's stem cell portfolio in June 2018?
- In June 2018, Biological Industries USA added Vitronectin XF™ to its stem cell portfolio through an agreement with Primorigen Biosciences, Inc.
- What type of agreement did Biological Industries USA sign with Mill Creek Life Sciences in March 2017?
- In March 2017, Biological Industries USA signed an agreement with Mill Creek Life Sciences to add PLTMax Human Platelet Lysate to its stem cell portfolio.
- When was Biological Industries founded?
- Biological Industries was founded in December 1990.
- What was the nature of the agreement between Biological Industries and Bartels Stek in September 2013?
- In September 2013, Biological Industries entered into a long-term agreement with Bartels Stek regarding Gypsophila.
- What was the purpose of the Mesenchymal Stromal and Stem Cell Research Award announced by Biological Industries USA in January 2018?
- In January 2018, Biological Industries USA announced the Mesenchymal Stromal and Stem Cell Research Award, which included conference travel, laboratory reagents, and potential publicity for researchers.